AstraZeneca delivered a strong performance in the first quarter of 2025, it announced on Tuesday, with total revenue rising ...

London stocks nudged lower in early trade on Tuesday as investors waded through a deluge of corporate releases from the likes ...

Specialist insurer Beazley reiterated its full-year outlook on Tuesday, after it posted a modest uptick in written premiums.

European shares opened higher on Tuesday amid a quarterly earnings dump and more economic uncertainty amid US President ...

Real estate services firm Savills announced on Tuesday that chief executive Mark Ridley will retire at the end of 2025 after ...

Entain has officially appointed interim boss Stella David as its new chief executive, as the sports betting and gaming group ...

Builders’ merchant Travis Perkins reported a drop in first-quarter sales on Tuesday as it said that trading remained ...

Howden Joinery plans to open 20 to 25 new depots in the UK this year and refurbish around 60 older locations as it announced that trading in the first four months of the year was in line with ...

AstraZeneca has discontinued its CAPItello-280 phase three trial assessing Truqap, or capivasertib, in combination with docetaxel and androgen-deprivation therapy (ADT) for patients with metastatic ...

Telecom Plus said on Tuesday that it delivered record customer growth, profits, and dividend increases in its financial year ...

Food producer Bakkavor said on Tuesday that it has agreed to sell its China operations to Lihe Xing (Qingdao) Food Technology ...

Troubled transport operator Mobico said chief executive Ignacio Garat would be stepping down, days after the company issued a profit alert that send its shares plunging by more than 40%.